U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H8O2
Molecular Weight 124.1372
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEQUINOL

SMILES

COC1=CC=C(O)C=C1

InChI

InChIKey=NWVVVBRKAWDGAB-UHFFFAOYSA-N
InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3

HIDE SMILES / InChI
Mequinol (mequinol is 4-hydroxyanisole) is an active ingredient in topical drugs used for skin depigmentation. The mechanism of action of mequinol is unknown. Although mequinol is a substrate for the enzyme tyrosinase and acts as a competitive inhibitor of the formation of melanin precursors, the clinical significance of these findings is unknown.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
SOLAGE

Approved Use

Mequinol is a depigmenting agent. The mechanism of depigmenting effects of mequinol remain unclear; speculations include oxidation by tyrosinase to cytotoxic products in melanocytes, a direct/selective toxic effect on melanocytes, or inhibition of melanin formation

Launch Date

1999
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
9.92 ng/mL
16 μL 1 times / day steady-state, topical
dose: 16 μL
route of administration: Topical
experiment type: STEADY-STATE
co-administered:
MEQUINOL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
33.43 ng × h/mL
16 μL 1 times / day steady-state, topical
dose: 16 μL
route of administration: Topical
experiment type: STEADY-STATE
co-administered:
MEQUINOL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
5 h
16 μL 1 times / day steady-state, topical
dose: 16 μL
route of administration: Topical
experiment type: STEADY-STATE
co-administered:
MEQUINOL plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
2 % 1 times / day steady, topical
Recommended
Dose: 2 %, 1 times / day
Route: topical
Route: steady
Dose: 2 %, 1 times / day
Sources:
healthy, 55.8 years
Health Status: healthy
Age Group: 55.8 years
Sex: M+F
Sources:
Disc. AE: Dermal and epidermal conditions NEC, Skin and subcutaneous tissue disorders...
Other AEs: Hematuria...
AEs leading to
discontinuation/dose reduction:
Dermal and epidermal conditions NEC (3.5%)
Skin and subcutaneous tissue disorders (5.8%)
Other AEs:
Hematuria (3.5%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Hematuria 3.5%
2 % 1 times / day steady, topical
Recommended
Dose: 2 %, 1 times / day
Route: topical
Route: steady
Dose: 2 %, 1 times / day
Sources:
healthy, 55.8 years
Health Status: healthy
Age Group: 55.8 years
Sex: M+F
Sources:
Dermal and epidermal conditions NEC 3.5%
Disc. AE
2 % 1 times / day steady, topical
Recommended
Dose: 2 %, 1 times / day
Route: topical
Route: steady
Dose: 2 %, 1 times / day
Sources:
healthy, 55.8 years
Health Status: healthy
Age Group: 55.8 years
Sex: M+F
Sources:
Skin and subcutaneous tissue disorders 5.8%
Disc. AE
2 % 1 times / day steady, topical
Recommended
Dose: 2 %, 1 times / day
Route: topical
Route: steady
Dose: 2 %, 1 times / day
Sources:
healthy, 55.8 years
Health Status: healthy
Age Group: 55.8 years
Sex: M+F
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer

Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
yes
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
The influence of fibrous elastomer structure and porosity on matrix organization.
2010-12-22
Pairwise substitution effects, inter- and intramolecular hydrogen bonds in methoxyphenols and dimethoxybenzenes. Thermochemistry, calorimetry, and first-principles calculations.
2010-12-16
Rate coefficients for the gas-phase reaction of hydroxyl radicals with 2-methoxyphenol (guaiacol) and related compounds.
2010-11-04
Structure and vibrational frequencies of 6,7-dimethoxy-1,4-dihydro-1,3-quinoxalinedione based on density functional theory calculations: The role of pi-electron conjugation and back-donation.
2010-09-15
Molecular characteristics of Kraft-AQ pulping lignin fractionated by sequential organic solvent extraction.
2010-08-16
Pi-selective stationary phases: (II) Adsorption behaviour of substituted aromatic compounds on n-alkyl-phenyl stationary phases.
2010-08-13
Synthesis and characterization of amine bridged bis(phenolate) lanthanide aryloxides and their application in the polymerization of lactide.
2010-08-07
Hydrogen hyperfine splitting constants for phenoxyl radicals by DFT methods: regression analysis unravels hydrogen bonding effects.
2010-07-21
Surface photochemistry of pesticides containing 4-chlorophenoxyl chromophore.
2010-07-15
Application of ex situ dynamic nuclear polarization in studying small molecules.
2010-06-14
Heterogeneous reaction of gaseous ozone with aqueous iodide in the presence of aqueous organic species.
2010-05-20
In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury.
2010-04
Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole.
2010-03
Strategic distribution of protective proteins within bran layers of wheat protects the nutrient-rich endosperm.
2010-03
Amperometric phenol biosensor based on horseradish peroxidase entrapped PVF and PPy composite film coated GC electrode.
2010-03
Radical-scavenging activity and cytotoxicity of p-methoxyphenol and p-cresol dimers.
2010-02-26
Marine natural meroterpenes: synthesis and antiproliferative activity.
2010-02-23
Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.
2010-02-12
Measurement of phenols dearomatization via electrolysis: the UV-Vis solid phase extraction method.
2010-02
Antioxidant activity of colored rice bran obtained at different milling yields.
2010
The hunt for natural skin whitening agents.
2009-12-10
Tris{2-meth-oxy-6-[(4-methyl-phen-yl)iminiometh-yl]phenolate-κO,O'}tris-(thio-cyanato-κN)europium(III).
2009-11-21
(E)-2-[(4-Ethoxy-phen-yl)imino-meth-yl]-4-methoxy-phenol.
2009-10-10
Development and evaluation of kinetic spectrophotometric assays for horseradish peroxidase by catalytic coupling of paraphenylenediamine and mequinol.
2009-10
6,6'-Dimeth-oxy-2,2'-[(E,E')-(4-chloro-m-phenyl-ene)bis-(nitrilo-methyl-idyne)]diphenol.
2009-09-30
Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration.
2009-09-15
Simulation of IR and Raman spectra of p-hydroxyanisole and p-nitroanisole based on scaled DFT force fields and their vibrational assignments.
2009-09-15
Increase in the levels of chaperone proteins by exposure to beta-estradiol, bisphenol A and 4-methoxyphenol in human cells transfected with estrogen receptor alpha cDNA.
2009-06
Current and emerging therapy for the management of vitiligo.
2009-03-12
Peroxidase-mediated degradation of perfluorooctanoic acid.
2009-02
Production of o-diphenols by immobilized mushroom tyrosinase.
2009-01-15
Urinary levoglucosan as a biomarker of wood smoke exposure: observations in a mouse model and in children.
2009-01
Topical treatment of melasma.
2009
Antiproliferative effects of honey and of its polyphenols: a review.
2009
Reaction of phenols with the 2,2-diphenyl-1-picrylhydrazyl radical. Kinetics and DFT calculations applied to determine ArO-H bond dissociation enthalpies and reaction mechanism.
2008-12-05
Results of a residential indoor PM2.5 sampling program before and after a woodstove changeout.
2008-10
The mechanism of the phosphoramidite synthesis of polynucleotides.
2008-09-21
Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines.
2008-09
Assessing urinary levoglucosan and methoxyphenols as biomarkers for use in woodsmoke exposure studies.
2008-08-25
Essential explanation of the strong mineralization performance of boron-doped diamond electrodes.
2008-07-01
A highly specific BODIPY-based fluorescent probe for the detection of hypochlorous acid.
2008-06-05
An efficient protocol for the enantioselective preparation of a key polyfunctionalized cyclohexane. New access to (R)- and (S)-4-Hydroxy-2-cyclohexenone and (R)- and (S)-trans-cyclohex-2-ene-1,4-diol.
2008-05-02
Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells.
2008-05
Laser flash photolysis study of the triplet reactivity of beta-lapachones.
2008-04
Efficient synthesis and properties of novel near-infrared electrochromic anthraquinone imides.
2008-02-21
Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature.
2008-02
Subcellular localization and cytoplasmic complex status of endogenous Keap1.
2007-10
Electrochemical oxidation characteristics of p-substituted phenols using a boron-doped diamond electrode.
2007-09-15
Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-kappaB.
2007-09
Physico-chemical studies on the evaluation of the antioxidant activity of herbal extracts and active principles of some Indian medicinal plants.
2007-05
Patents

Sample Use Guides

Apply Solagé to the solar lentigines using the applicator tip while avoiding application to the surrounding skin. Use twice daily, morning and evening at least 8 hours apart, or as directed by a physician. Patients should not shower or bathe the treatment areas for at least 6 hours after application of Solagé. Special caution should be taken when applying Solagé to avoid the eyes, mouth, paranasal creases, and mucous membranes.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Name Type Language
P-HYDROXYANISOLE
INCI  
INCI  
Preferred Name English
MEQUINOL
HSDB   INN   MART.   ORANGE BOOK   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
SOLAGE COMPONENT MEQUINOL
Common Name English
4-Methoxyphenol
Systematic Name English
Mequinol [WHO-DD]
Common Name English
4-HYDROXYANISOLE
INCI  
Systematic Name English
MEQUINOL [ORANGE BOOK]
Common Name English
MEQUINOL [MART.]
Common Name English
NSC-4960
Code English
MEQUINOL [USAN]
Common Name English
PHENOL, 4-METHOXY-
Systematic Name English
BMS-181158
Code English
MEQUINOL [HSDB]
Common Name English
mequinol [INN]
Common Name English
MEQUINOL [VANDF]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C78284
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
NDF-RT N0000175851
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
WHO-ATC D11AX06
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
NDF-RT N0000175855
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
NDF-RT N0000175850
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
CFR 21 CFR 176.170
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
WHO-VATC QD11AX06
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
Code System Code Type Description
DRUG BANK
DB09516
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
CAS
150-76-5
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
ChEMBL
CHEMBL544
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
HSDB
4258
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
RXCUI
15080
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY RxNorm
FDA UNII
6HT8U7K3AM
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
INN
1542
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
IUPHAR
6827
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-769-8
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
EVMPD
SUB08764MIG
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID4020828
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
SMS_ID
100000081706
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
USAN
LL-42
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
NCI_THESAURUS
C47604
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
DRUG CENTRAL
4221
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
MESH
C009760
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
NSC
4960
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
PUBCHEM
9015
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY
WIKIPEDIA
MEQUINOL
Created by admin on Mon Mar 31 17:34:41 GMT 2025 , Edited by admin on Mon Mar 31 17:34:41 GMT 2025
PRIMARY